Chang-Gyu Jung

Chang-Gyu Jung

Auto-generated profile, based on publicly available information

Chang-Gyu Jung

Department of Allergy and Clinical Immunology Keimyung University School of Medicine Daegu South Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
YLYoungsoo Lee
Youngsoo Lee
Ji-Ho LeeJi-Ho Lee
Ji-Ho Lee
EYEun-Mi Yang
Eun-Mi Yang
EKEunMi Kwon
EunMi Kwon
CJChang-Gyu Jung
Chang-Gyu Jung
HPHae-Sim Park
Hae-Sim Park
Lee Y, et al. Allergy Asthma Immunol Res. 2019 May;11(3):394-405. https://doi.org/10.4168/aair.2019.11.3.394

18 October 2020 in Allergy
Verified
Journal Article
Closed access
SKSujeong Kim
Sujeong Kim
CJChang‐Gyu Jung
Chang‐Gyu Jung
JLJi Yeon Lee
Ji Yeon Lee
GKGunwoo Kim
Gunwoo Kim
SCSae Won Choi
Sae Won Choi
HPHan-Ki Park
Han-Ki Park

3 April 2023 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
CJChang‐Gyu Jung
Chang‐Gyu Jung
TCThi Bich Tra Cao
Thi Bich Tra Cao
QQQuang Luu Quoc
Quang Luu Quoc
EYEun‐Mi Yang
Eun‐Mi Yang
GBGa Young Ban
Ga Young Ban
HPHae-Sim Park
Hae-Sim Park

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
Ji-Ho LeeJi-Ho Lee
Ji-Ho Lee
SKSu-Chin Kim
Su-Chin Kim
HCHyunna Choi
Hyunna Choi
CJChang-Gyu Jung
Chang-Gyu Jung
GBGa Young Ban
Ga Young Ban
YYYoung-Min Ye
Young-Min Ye
Lee JH, et al. J Korean Med Sci. 2017 Jul;32(7):1124-1130. https://doi.org/10.3346/jkms.2017.32.7.1124

13 September 2025 in Allergy
Verified
Journal Article
Open access
KKKanokvalai Kulthanan
Kanokvalai Kulthanan
JBJonathan Bernstein
Jonathan Bernstein
MRMichael Rudenko
Michael Rudenko
Pascale SalamehPascale Salameh
Pascale Salameh
CKChulaluk Komoltri
Chulaluk Komoltri
Torsten ZuberbierTorsten Zuberbier
Torsten Zuberbier
Background: The prevalence of symptomatic dermographism ( SD ) in the general population remains unclear. This study aimed to internationally estimate the prevalence of SD and two other dermographic subtypes—physiological red dermographism and simple urticarial dermographism—among adults worldwide. Methods: The PREVALENCE ‐D (Prevalence Estimation of Dermographism) study was the largest international, cross‐sectional, internet‐based investigation conducted by the Urticaria Centers of Reference and Excellence of the Global Allergy and Asthma Excellence Network from 2021 to 2024. A world expert‐designed questionnaire was completed by participants from 28 centers across 19 countries to diagnose SD . Participants were recruited into three age groups (18–24, 25–60, and > 60 years), with ≥ 1000 individuals per group per country. We calculated sex‐ and age‐adjusted prevalence estimates internationally and by country, with 95% confidence intervals. Results: Among 59,543 participants worldwide, those with SD had an adjusted point prevalence of 3.20% (95% confidence interval [ CI ] 2.68%–3.73%) and a lifetime prevalence of 5.94% (95% CI 5.32%–6.56%). The 25–60 years group presented the highest prevalence. Females had higher rates than males, with statistically significant differences across all age groups for both point and lifetime prevalence. Physiological red dermographism had an adjusted point prevalence of 10.02% (95% CI 9.48%–10.55%) and a lifetime prevalence of 33.47% (95% CI 32.01%–34.94%). Simple urticarial dermographism showed an adjusted point prevalence of 1.21% (95% CI 1.08%–1.35%) and a lifetime prevalence of 5.39% (95% CI 4.99%–5.79%). Conclusion: These findings provide comprehensive international estimates of dermographism, particularly SD , and emphasize the need for appropriate healthcare resource allocation and disease recognition.

1 November 2022 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
HPHae-Sim Park
Hae-Sim Park
CJChang-Gyu Jung
Chang-Gyu Jung
Hop Japanese (Hop J) pollen has been considered one of the major causative pollen allergens in Far East Asia in the autumn season. The sensitization rate, pollen count, and allergenicity of Hop J pollens are increasing in this region because of increased air pollution and global warming. However, commercial skin test agents for the diagnosis and allergen extracts for the allergen immunotherapy are not available. This review summarizes recent data on clinical impact of Hop J pollinosis in order to facilitate the development of diagnostic and therapeutic agents for this region.